According to Hast et al., KEAP1 mutations, including N469fs, P318fs, R554Q, W544C, and G333C, disrupt Keap1-Nrf2 binding in lung squamous cell carcinoma. This evidence concerns the gene KEAP1 and squamous cell lung carcinoma.